IL314472A - Product purification methods - Google Patents
Product purification methodsInfo
- Publication number
- IL314472A IL314472A IL314472A IL31447224A IL314472A IL 314472 A IL314472 A IL 314472A IL 314472 A IL314472 A IL 314472A IL 31447224 A IL31447224 A IL 31447224A IL 314472 A IL314472 A IL 314472A
- Authority
- IL
- Israel
- Prior art keywords
- purifying
- methods
- product
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/248—IL-6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263267810P | 2022-02-10 | 2022-02-10 | |
| PCT/US2023/062322 WO2023154822A2 (en) | 2022-02-10 | 2023-02-09 | Methods of purifying a product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL314472A true IL314472A (en) | 2024-09-01 |
Family
ID=87521638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL314472A IL314472A (en) | 2022-02-10 | 2023-02-09 | Product purification methods |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230250133A1 (https=) |
| EP (1) | EP4476237A2 (https=) |
| JP (1) | JP2025505696A (https=) |
| KR (1) | KR20240142564A (https=) |
| CN (1) | CN119032099A (https=) |
| AU (1) | AU2023217074A1 (https=) |
| CA (1) | CA3251000A1 (https=) |
| IL (1) | IL314472A (https=) |
| MX (1) | MX2024009755A (https=) |
| WO (1) | WO2023154822A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015035342A2 (en) | 2013-09-08 | 2015-03-12 | Oligasis Llc | Factor viii zwitterionic polymer conjugates |
| CA3059938A1 (en) | 2017-04-14 | 2018-10-18 | Kodiak Sciences Inc. | Complement factor d antagonist antibodies and conjugates thereof |
| EP3758737A4 (en) | 2018-03-02 | 2022-10-12 | Kodiak Sciences Inc. | IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF |
| CA3157509A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| WO2025073922A1 (en) * | 2023-10-04 | 2025-04-10 | Sartorius Bia Separations D.O.O. | Enhanced chromatographic separations of components in a mixture by employing chaotropic elution |
| WO2025184423A1 (en) * | 2024-02-29 | 2025-09-04 | Kodiak Sciences Inc. | Cell-surface-targeting-domain-polymer-payload conjugate |
| WO2026055308A1 (en) * | 2024-09-06 | 2026-03-12 | Merck Sharp & Dohme Llc | Multivalent fzd4, wnt co-receptor, and vegf receptor molecules and uses thereof |
| US20260092125A1 (en) * | 2024-09-06 | 2026-04-02 | Eyebiotech Limited | Multivalent fzd4, wnt co-receptor, and vegf binding molecules and uses thereof |
| WO2026075981A1 (en) * | 2024-10-01 | 2026-04-09 | Regeneron Pharmaceuticals, Inc. | Methods of analyzing heterodimeric proteins |
| CN119454939A (zh) * | 2024-11-28 | 2025-02-18 | 北海康成(苏州)生物制药有限公司 | 一种欧莫扑拜单抗原液及其制备方法 |
| CN119524125A (zh) * | 2024-11-28 | 2025-02-28 | 北海康成(苏州)生物制药有限公司 | 一种欧莫扑拜单抗原液的生产方法及欧莫扑拜单抗原液 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7045314B2 (en) * | 2000-04-04 | 2006-05-16 | Baxter International Inc. | Method for the production of bacterial toxins |
| WO2010147686A2 (en) * | 2009-03-11 | 2010-12-23 | Wyeth Llc | Methods of purifying small modular immunopharmaceutical proteins |
| JP6162707B2 (ja) * | 2011-10-24 | 2017-07-12 | ハロザイム インコーポレイテッド | 抗ヒアルロナン剤治療のためのコンパニオン診断およびその使用方法 |
| CN105899540B (zh) * | 2014-01-03 | 2020-02-07 | 豪夫迈·罗氏有限公司 | 双特异性抗-半抗原/抗-血脑屏障受体的抗体、其复合物及它们作为血脑屏障穿梭物的应用 |
| MX380658B (es) * | 2014-01-15 | 2025-03-11 | Hoffmann La Roche | Variantes de region fc con union mejorada de la proteina a. |
| EP3054007A1 (en) * | 2015-02-09 | 2016-08-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step |
| PE20181363A1 (es) * | 2015-09-23 | 2018-08-27 | Genentech Inc | Variantes optimizadas de anticuerpos anti-vegf |
| KR20250057128A (ko) * | 2015-12-30 | 2025-04-28 | 코디악 사이언시스 인코포레이티드 | 항체 및 이의 접합체 |
| EP3758737A4 (en) * | 2018-03-02 | 2022-10-12 | Kodiak Sciences Inc. | IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF |
| US20210254073A1 (en) * | 2020-02-04 | 2021-08-19 | Cornell University | Methods for capture and analysis of macromolecular complexes |
-
2023
- 2023-02-09 AU AU2023217074A patent/AU2023217074A1/en active Pending
- 2023-02-09 US US18/166,755 patent/US20230250133A1/en active Pending
- 2023-02-09 MX MX2024009755A patent/MX2024009755A/es unknown
- 2023-02-09 IL IL314472A patent/IL314472A/en unknown
- 2023-02-09 KR KR1020247030267A patent/KR20240142564A/ko active Pending
- 2023-02-09 CN CN202380033420.7A patent/CN119032099A/zh active Pending
- 2023-02-09 JP JP2024547315A patent/JP2025505696A/ja active Pending
- 2023-02-09 EP EP23753671.9A patent/EP4476237A2/en active Pending
- 2023-02-09 CA CA3251000A patent/CA3251000A1/en active Pending
- 2023-02-09 WO PCT/US2023/062322 patent/WO2023154822A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA3251000A1 (en) | 2023-08-17 |
| KR20240142564A (ko) | 2024-09-30 |
| JP2025505696A (ja) | 2025-02-28 |
| MX2024009755A (es) | 2024-08-20 |
| WO2023154822A2 (en) | 2023-08-17 |
| AU2023217074A1 (en) | 2024-08-15 |
| CN119032099A (zh) | 2024-11-26 |
| WO2023154822A3 (en) | 2023-09-21 |
| EP4476237A2 (en) | 2024-12-18 |
| WO2023154822A8 (en) | 2024-04-04 |
| US20230250133A1 (en) | 2023-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL314472A (en) | Product purification methods | |
| GB202001121D0 (en) | Process for there synthesis of buprenorphine | |
| NO20190144A1 (en) | A process for production of aluminium | |
| GB202202060D0 (en) | Product | |
| GB202403366D0 (en) | Product | |
| PT4172136T (pt) | Método de purificação de metanol bruto | |
| IL326885A (en) | Risdiplam purification process | |
| GB202105882D0 (en) | A synthesis method of saxagliptin intermediate | |
| HK40100763A (zh) | 截短侧耳素的纯化方法 | |
| GB202211033D0 (en) | Purification process | |
| CA3292747A1 (en) | A process for purification of ethofumesate | |
| ZA202105424B (en) | A method of producing a high protein product | |
| GB202306624D0 (en) | Pelletisation of a mineral product | |
| GB202511650D0 (en) | Product | |
| GB202511281D0 (en) | Product | |
| GB202510997D0 (en) | Floorcare product | |
| GB202510313D0 (en) | Product | |
| GB202508503D0 (en) | Product | |
| GB202507678D0 (en) | Product | |
| GB202506897D0 (en) | Product | |
| GB202506898D0 (en) | Product | |
| GB202416248D0 (en) | Purification process | |
| GB202504142D0 (en) | Product | |
| GB202418716D0 (en) | Product | |
| GB202417304D0 (en) | Product |